Evidence map›Paper›PMID 38492164›Full record

ArticleCerebellum (London, England)2024

Quantitative Evaluation of Stance as a Sensitive Biomarker of Postural Ataxia Development in Preclinical SCA1 Mutation Carriers.

Anna Sobanska, Leszek Czerwosz, Anna Sulek, Rafal Rola, Iwona Stepniak, Maria Rakowicz

Abstract read
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Physiotherapy in Spinocerebellar Ataxia Following COVID-19: A Biomechanical and Biopsychosocial Case Report.Physiotherapy research international : the journal for researchers and clinicians in physical therapy · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Anna SobanskaDepartment of Clinical Neurophysiology, Institute of Psychiatry and Neurology, Warsaw, Poland. asobanska@ipin.edu.pl.ORCID http://orcid.org/0000-0002-7129-913X
Leszek CzerwoszLaboratory of Respiration Physiology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.ORCID http://orcid.org/0000-0002-9904-5748
Anna SulekDepartment of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland.ORCID http://orcid.org/0000-0003-2975-4888
Rafal RolaDepartment of Neurology, Military Institute of Aviation Medicine, Warsaw, Poland.ORCID http://orcid.org/0000-0002-9388-5578
Iwona StepniakDepartment of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland.ORCID http://orcid.org/0000-0001-9793-2901
Maria RakowiczFirst Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.ORCID http://orcid.org/0000-0003-3998-8936
Institute of Psychiatry and Neurology · PLMossakowski Medical Research Institute, Polish Academy of Sciences · PLUczelnia Łazarskiego · PLWojskowy Instytut Medycyny Lotniczej · PL

Funding

Ministerstwo Edukacji i Nauki 501-061-16038
6 · The paper itself

Abstract

The aim of this study was to determine the time between the first detection of postural control impairments and the evident manifestation of ataxia in preclinical SCA1 individuals. Twenty five preclinical SCA1 mutation carriers: 13 with estimated disease onset ≤ 6 years (SCA1 +) aged 27.8 ± 8.1 years; 12 with expected disease onset > 6 years (SCA1-) aged 26.6 ± 3.1 years and 26 age and sex matched healthy controls (HCs) underwent static posturography during 5 years of observation. The movements of the centre of feet pressure (COP) during quiet standing with eyes open (EO) and closed (EC) were quantified by calculating the mean radius (R), developed surface area (A) and mean COP movement velocity (V). Ataxia was evaluated by use of the Scale for Assessment and Rating of Ataxia (SARA).SCA1 + exhibited significantly worse quality of stance with EC vs. SCA1- (p < 0.05 for V) and HCs (p < 0.001) even 5 to 6 years before estimated disease onset. There were no statistically significant differences between SCA1- and HCs. A slow increase in Cohen's d effect size was observed for V

Indexed as

HeterozygoteMutationPostural BalanceSpinocerebellar AtaxiasAdultAtaxiaAtaxin-1BiomarkersDisease ProgressionFemaleHumansMaleYoung AdultAtaxin-1ATXN1 protein, humanBiomarkersBalanceCentre of Feet PressurePosturographyPreclinical Spinocerebellar Ataxia Type 1

Identifiers

PMID38492164
OpenAlexW4392883848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.